ISMIVS Newsletter November & December, 2025 Newsletter ISMIVS

ISMIVS Newsletter November & December, 2025

Newsletter 2025 November & December
2025年11&12月简报

About Us 国际微无创医学会简介

The International Society of Minimally Invasive and Virtual Surgery (ISMIVS, previously known as International Society of Minimally Invasive and Noninvasive Medicine) was founded in July 2013 at the gala of the 1st Yangtze International Summit of Minimally Invasive and Noninvasive Medicine in Chongqing, China. ISMIVS envisions to accelerating the progress in minimally invasive and noninvasive medicine by promoting research, education, communication, and international collaboration.
国际微无创医学会（ISMIVS）是在 2013 年 7 月在中国重庆召开的第一届国际微无创医学长江高峰论坛上宣布成立的，旨在通过学术研究、教育、交流以及国际合作加快微无创医学的发展。

Become a member 注册成为会员 >

Ideas about Young ISMIVS 医路青春专访栏目

Ideas about Young ISMIVS
医路青春专访栏目

In July 2023, the Young ISMIVS Committee was formally established in order to respond to the development trend of minimally invasive and noninvasive medicine, and further consolidate the core group of young physicians.
为顺应微无创医学发展的趋势，进一步凝聚中青年微无创医学骨干的力量，推动微无创医学的发展。2023年7月，国际微无创医学会“青年委员会”（以下简称“青委会”）正式成立。
As the youth force of the new era in the field of minimally invasive and noninvasive medicine, the Young ISMIVS Committee carries the important mission of enlightening medical innovation and leading the development of this field. It will become a solid pillar to promote the breakthroughs in minimally invasive and noninvasive medicine to new heights through its unique vitality and profound deposits.
青委会作为微无创领域新时代的青春力量，承载着启迪医学创新、引领微无创技术发展的重要使命，将凭借其独特的创新活力和深厚的专业积淀，成为推动微无创领域不断突破、迈向新高峰的坚实砥柱。
In medicine, a group of passionate young physicians, who harbor the love and persistence for minimal invasiveness and non-invasiveness, keep exploring and moving forward. They are the members of the Young ISMIVS Committee, who contribute to the development of this field with their enthusiasm and wisdom.
在医学的广阔天地里，这样一群热血的青年医者，他们怀揣着对微无创医学的热爱与执着，不断探索、不断前行。他们，正是青委会的成员，他们以青春的热情与智慧，为微无创医学的发展贡献着自己的力量。
In conjunction with Da Yi Wei Ke, we are now introducing the first interview show – Ideas about Young ISMIVS. Let's get closer to this group of young doctors, listen to their stories on the path of minimally invasive and non-invasive medicine, feel their passion and persistence, and witness the bright future together.
国际微无创医学会青年委员会联合大医微课策划出品，首档人物专访节目《医路青春》正在播出。让我们走近这群青年医者，聆听他们在微无创路上的成长故事，感受他们的热情与执着，共同见证微无创医学的辉煌未来。

Ideas about Young ISMIVS with:
本期嘉宾：

Zhu Xiaogang
Doctor of Medicine, Postdoctoral Fellow
The Third Xiangya Hospital, Central South University
朱小刚
医学博士、博士后
中南大学湘雅三医院

-Standing Committee Member, Young ISMIVS Committee
-Member, Clinical Research and Quality Control Subcommittee, Chinese Medical Doctor Association Minimally Invasive Medicine Committee
-Member, Focused Ultrasound Ablation Therapy Subcommittee, Ultrasound Therapy and Biological Effects Committee
-Senior Lecturer, FUS International Clinical Training Base
-国际微无创医学会青年委员会常务委员
-中国医师协会微无创专业委员会“临床研究与质控”专业学组委员
-超声治疗及生物学效应专业委员会聚焦超声消融治疗学组委员

Watch the interview:

https://youtu.be/mI4ui76RiOQ?si=ARk29sjOOcoyl7M5

观看本期采访：

https://mp.weixin.qq.com/s/knr9noTw6bKQXre_NM6uOg

News 新闻

Parallel Session of ISMINIM 2025:
Minimally Invasive and Non-Invasive Therapy for Adenomyosis
2025 微无创医学长江论坛分会场精彩速递：微无创治疗子宫腺肌症

Guo Lei, President of the Western Guangdong Women and Children's Hospital of Guangdong Provincial Second People's Hospital; Wang Qingyuan, Department of Obstetrics and Gynecology, Second Affiliated Hospital of Anhui Medical University; Yang Liping, Director of the Gynecology Diagnosis and Treatment Center, Jilin Central Hospital; and Mary Karen Ocampo Atanacio, MD, University of Santo Tomas (Philippines), served as moderators of this session..
广东省第二人民医院粤西妇女儿童医院院长郭蕾、安徽医科大学第二附属医院妇产科王青元、吉林市中心医院妇科诊治中心主任杨丽萍、圣托马斯大学医学博士Mary Karen Ocampo Atanacio （菲律宾）担任主持。

Professor Yu Xin, Deputy Director of the General Gynecology Center at Peking Union Medical College Hospital, conducted an in-depth exploration of the therapeutic advances in high-intensity focused ultrasound ablation for different subtypes of adenomyosis. By analyzing clinical data, she examined the variations in treatment response across subtypes and proposed personalized therapeutic strategies to enhance treatment efficacy.
北京协和医院妇产科普通妇科中心副主任于昕教授深入探讨了不同分型子宫腺肌症的高强度聚焦超声消融治疗进展，结合临床数据分析了各分型的治疗反应差异，并提出了个体化治疗策略以提高疗效。
Professor Zi Dan, Director of the Department of Obstetrics and Gynecology at Guizhou Provincial People's Hospital, systematically summarized the current application of focused ultrasound in the treatment of adenomyosis. The presentation focused on the selection of indications, energy regulation, and the impact of postoperative follow-up on long-term prognosis.
贵州省人民医院妇产科教研室主任訾聃教授系统总结了聚焦超声在子宫腺肌病治疗中的应用现状，重点讨论了适应症选择、能量调控及术后随访对长期预后的影响。
Professor He Hongying from Guangzhou Women and Children's Medical Center Liuzhou Hospital, Professor Jin Haihong, Director of Gynecology at Qinhuangdao First Hospital, and Professor Zhang Chunlian from Shiyan Taihe Hospital engaged in a discussion session focused on optimizing focused ultrasound techniques for treating adenomyosis. They emphasized the critical role of multidisciplinary collaboration in enhancing ablation precision and reducing complications.
广州市妇女儿童医疗中心柳州医院贺红英教授、秦皇岛市第一医院妇科主任金海红教授和十堰市太和医院张春莲教授在讨论环节围绕聚焦超声治疗子宫腺肌症的技术优化展开交流，强调多学科协作在提高消融精准度和减少并发症中的关键作用。
Professor Aixingzi Aili, Deputy Director of the HIFU Center at Shanghai First Maternity and Infant Hospital, shared insights on long-term management of adenomyosis through focused ultrasound ablation combined with medication. She proposed that an integrated approach of “non-invasive treatment plus medication maintenance” can significantly alleviate symptoms and reduce recurrence rates.
上海市第一妇婴保健院海扶中心副主任艾星子•艾里教授分享了聚焦超声消融技术联合药物长期管理子宫腺肌症的经验，提出“无创治疗+药物维持”的综合模式可显著缓解症状并降低复发率。
Professor Tan Ee Ping, a senior minimally invasive and robot-assisted surgeon in Malaysia, presented the clinical practice of microwave ablation therapy for adenomyosis in Malaysia. She conducted a comparative analysis of the technical characteristics of microwave and HIFU technologies in terms of penetration depth and thermal field distribution.
马来西亚高级微创手术及机器人协助手术外科医生陈意萍教授介绍了马来西亚子宫腺肌症微波消融治疗的临床实践，对比分析了微波与HIFU在穿透深度和热场分布上的技术特点。
Professor Oliver Cruz from the Department of Obstetrics and Gynecology at the National Autonomous University of Mexico, Vice President Li Jingjing of Liuzhou Maternal and Child Health Hospital, and Professor Yang Hongbo, Director of Gynecology at Huai'an Maternal and Child Health Hospital, discussed the application of ablation techniques in adenomyosis, as well as postoperative fertility assessment and long-term management strategies.
墨西哥国立自治大学妇产科Oliver Cruz教授、柳州市妇幼保健院副院长李晶晶、淮安市妇幼保健院妇科主任杨洪波教授在讨论中探讨了消融技术在子宫腺肌症的应用，以及术后生育力评估和长期管理方案。

Watch the playback of the Summit:

https://www.youtube.com/playlist?list=PLWbjlVbxcLm3p9sE4xg3Z8YdcvZ4xOuYj

观看会议回放：

https://live.dayiweike.com/video/huikan/1980?m=jin

New Perspective in Focused Ultrasound 聚焦超声新视角

Factors influencing the volume reduction rate of ultrasound-guided high-intensity focused ultrasound for breast fibroadenoma
影响超声引导下高强度聚焦超声治疗乳腺纤维腺瘤体积缩减率的因素

To investigate the factors influencing the volume reduction rate (VRR) at 12 months after ultrasound (US)-guided high-intensity focused ultrasound (HIFU) for breast fibroadenoma (FA).

为探讨超声引导下高强度聚焦超声（HIFU）治疗乳腺纤维腺瘤（FA）后12个月体积缩减率（VRR）的影响因素。

A retrospective analysis of 104 patients with 302 FAs who underwent US-guided HIFU from January 2021 to May 2023 was conducted. All patients received US assessment and contrast-enhanced US (CEUS) evaluation, and treatment information was recorded. VRR ≥ 80% was set as the dependent variable, while nineteen baseline- and treatment-related factors were considered as the independent variables. A logistic regression model was constructed to predict 12-month VRR.

对 2021 年1月至 2023 年 5 月期间接受超声引导下 HIFU 治疗的 104 例患者（共 302 处FA）进行回顾性分析。所有患者均接受超声评估及增强超声（CEUS）检查，并记录治疗信息。以体积缩减率≥80% 作为因变量，19 项基线及治疗相关因素作为自变量。构建逻辑回归模型预测 12 个月体积缩减率。

All patients successfully underwent one-session HIFU. Significant differences were observed in volume, distance from the superficial margin of FA to skin, distance from the deep margin of FA to chest wall, mean power, energy efficacy factor, type of near-field acoustic pathway, and appearance of hyperechoic changes. Multivariate analysis revealed that type of near-field acoustic pathway, distance from the deep margin of FA to chest wall, and appearance of hyperechoic changes were independent predictors of the 12-month VRR after HIFU. The area under Receiver Operating Characteristic curve was 0.688.

所有患者均成功接受单次 HIFU 治疗。在治疗体积、FA浅缘至皮肤距离、FA深缘至胸壁距离、平均功率、能量效率因子、近场声学路径类型及高回声改变表现方面均观察到显著差异。多变量分析显示，近场声学通路类型、FA深缘至胸壁距离及高回声改变表现是HIFU治疗后 12 个月 VRR 的独立预测指标。受试者工作特征曲线下面积为0.688。

The type of near-field acoustic pathway, distance from the deep margin of FA to chest wall, and appearance of hyperechoic changes could serve as predictors of 12-month VRR following HIFU treatment for FA.

近场声学通路类型、FA深缘至胸壁距离及高回声改变表现可作为 HIFU 治疗FA后 12 个月 VRR 的预测指标。

Tech Update in Gynaecological Endoscopy 妇科腔镜技术最新进展

Hysteroscopic adhesiolysis under conscious sedation and local anesthesia in an outpatient setting: A large retrospective study
在门诊条件下采用清醒镇静及局部麻醉下的宫腔镜下粘连松解术：一项大型回顾性研究

This study reviews the outcome of a series of hysteroscopic adhesiolysis (HA) in an outpatient setting.
本研究回顾性分析了门诊宫腔镜粘连松解术（HA）的一系列治疗结果。
This is a retrospective case series study performed at a fertility center. A total of 1073 women with mild, moderate, or severe intrauterine adhesions (IUAs) underwent HA between January 2011 and December 2023. Fourteen women who underwent HA under regional or general anesthesia were excluded. The remaining 1059 women were scheduled for HA in an outpatient setting under conscious sedation and local anesthesia. At the end of the HA procedure, within 1 min, the severity of discomfort or pain was assessed using the visual analogue scale (VAS).
该研究为生育中心开展的回顾性病例系列研究。2011 年 1 月至 2023 年 12 月期间，共 1073 例轻度、中度或重度宫腔粘连（IUAs）女性接受了HA治疗。其中 14 例在区域麻醉或全身麻醉下接受 HA 的患者被排除。其余 1059 例患者均在门诊环境下接受清醒镇静及局部麻醉下的HA手术。术后 1 分钟内，通过视觉模拟量表（VAS）评估患者不适或疼痛程度。
Hysteroscopic adhesiolysis was successfully performed under conscious sedation and local anesthesia in 1051 (97.9%) women during the study period. The mean age of the participants was 38.2 ± 5.25 years. The mean VAS score was 1.46 ± 1.18. In women with mild, moderate, and severe IUAs, the scores were 0.77, 1.42, and 2.49, respectively. In nine (0.9%) women, a uterine perforation occurred. Of the 618 (58.8%) women with complete follow-up, 140 (27.7%) conceived. In women with mild, moderate, and severe IUAs, the miscarriage rates were, respectively, 15.9%, 19.0%, and 60%. The live birth rates were 16.9%, 9.5%, and 1.4%, respectively.
在研究期间，1051 名（97.9%）女性在清醒镇静和局部麻醉下成功接受了宫腔镜粘连松解术。参与者平均年龄为 38.2±5.25 岁，平均视觉模拟评分（VAS）为 1.46±1.18。轻度、中度及重度宫腔粘连患者的评分分别为0.77、1.42和2.49。9 例（0.9%）患者发生子宫穿孔。在 618 例（58.8%）完成全程随访的患者中，140 例（27.7%）成功受孕。轻度、中度及重度宫腔粘连患者的流产率分别为 15.9%、19.0%和60%，活产率分别为 16.9%、9.5%和1.4%。
Hysteroscopic adhesiolysis in an outpatient setting under conscious sedation and local anesthesia appears feasible and is well tolerated, with a low complication rate. Given the retrospective nature of the study, the results should be interpreted with caution. Future studies are needed to evaluate HA under conscious sedation and local anesthesia, including long-term fertility and reproductive outcomes.
在门诊条件下采用清醒镇静联合局部麻醉进行宫腔镜下粘连松解术具有可行性且耐受性良好，并发症发生率低。鉴于本研究为回顾性设计，结果解读需谨慎。未来需开展更多研究评估清醒镇静联合局部麻醉下宫腔镜治疗的长期生育及生殖结局。